Effectiveness of Various Chlorhexidine-Based Insertion Site Protocols in Preventing CRBSI among Hemodialysis Patients: A Systematic Review and Synthesis Without Meta-analysis (SWiM)

Authors

  • Sri Hariyanti Universitas Indonesia & Rumah Sakit Universitas Indonesia
  • Yulia Yulia Universitas Indonesia
  • Dikha Ayu Kurnia Universitas Indonesia

DOI:

https://doi.org/10.37287/ijghr.v8i4.2012

Keywords:

catheter-related bloodstream infection, central venous catheter, chlorhexidine, hemodialysis, insertion site care, synthesis without meta-analysis

Abstract

Chronic Kidney Disease (CKD) is a global health issue affecting 10–15% of the world's population, often progressing to End-Stage Renal Disease (ESRD). Hemodialysis (HD) is the primary renal replacement therapy; however, the use of a Central Venous Catheter (CVC) for vascular access increases the risk of Catheter-Related Bloodstream Infections (CRBSI). Skin pathogens such as Staphylococcus aureus account for 40–80% of CRBSI cases, contributing to increased morbidity and mortality. The use of chlorhexidine (Chlorhexidine Gluconate/CHG) at the insertion site aims to inhibit extraluminal bacterial colonization. However, the effectiveness of various CHG protocols remains a subject of debate due to the risk of contact dermatitis and cost-effectiveness. This systematic review aims to evaluate the effectiveness of various chlorhexidine-based insertion site care protocols in preventing CRBSI events in hemodialysis patient. This systematic review was conducted in accordance with the PRISMA 2020 guidelines, using the “Synthesis Without Meta-analysis” approach, and is registered with PROSPERO 2026 under CRD420261368887. A search was conducted in the EBSCO, PubMed, Sage Journals, ScienceDirect, Scopus, and Wiley databases using the keyword “chlorhexidine-based catheter insertion care for the prevention of CRBSI.” Articles published between 2010 and 2025 were searched, resulting in a total of 1,412 articles identified from the initial database search.. A total of 7 articles meeting the inclusion criteria, consisting of RCTs and quasi-experimental studies. The outcomes analyzed included catheter-related infections such as CRBSI, CLABSI, and CRI. The direction of effects was analyzed narratively, and study quality was assessed using RoB 2 and JBI. Four studies showed a reduction in the incidence of infection, while three studies showed no significant difference. No increased risk of infection was found in any of the studies. Most studies used chlorhexidine sponges or patches (4 studies, 57%); 28% used chlorhexidine-impregnated dressings; and the remainder used chlorhexidine solution. Most studies were of moderate to good quality, with some potential for bias. Three studies showed p-values < 0.05. Chlorhexidine-based care protocol interventions show a tendency to reduce catheter-related infections in hemodialysis, but results remain inconsistent. The implementation of evidence-based nursing practices, particularly tailored to tunneled and non-tunneled catheters, is necessary to optimize infection prevention.

References

Apata, I. W., Hanfelt, J., Bailey, J. L., & Niyyar, V. D. (2017). Chlorhexidine-impregnated transparent dressings decrease catheter-related infections in hemodialysis patients: A quality improvement project. The Journal of Vascular Access , 18 (2), 103–108. https://doi.org/10.5301/jva.5000658

Azzopardi, A., & Trapani, J. (2024). Chlorhexidine‐based versus non‐chlorhexidine dressings to prevent catheter‐related bloodstream infections: An evidence‐based review. Nursing in Critical Care , 29 (1), 191–195. https://doi.org/10.1111/nicc.12879

Buetti, N., Ruckly, S., Schwebel, C., Mimoz, O., Souweine, B., Lucet, J.-C., & Timsit, J.-F. (2020). Chlorhexidine-impregnated sponge versus chlorhexidine gel dressing for short-term intravascular catheters: Which one is better? Critical Care , 24 (1), 458. https://doi.org/10.1186/s13054-020-03174-0

Camins, B. C. (2013). Prevention and Treatment of Hemodialysis-Related Bloodstream Infections. Seminars in Dialysis , 26 (4), 476–481. https://doi.org/10.1111/sdi.12117

Campbell, M., McKenzie, J.E., Sowden, A., Katikireddi, S.V., Brennan, S.E., Ellis, S., Hartmann-Boyce, J., Ryan, R., Shepperd, S., Thomas, J., Welch, V., & Thomson, H. (2020). Synthesis without meta-analysis (SWiM) in systematic reviews: Reporting guideline. BMJ , l6890. https://doi.org/10.1136/bmj.l6890

Heimann, S.M., Biehl, L.M., Vehreschild, J.J., Franke, B., Cornely, O.A., & Vehreschild, M.J.G.T. (2018). Chlorhexidine-containing dressings in the prevention of central venous catheter-related bloodstream infections: A cost and resource utilization analysis. American Journal of Infection Control , 46 (9), 992–997. https://doi.org/10.1016/j.ajic.2018.03.006

Hustrini, NM, Susalit, E., Harimurti, K., Haryoso, IS, Legrans, AE, Damarjati, K., Minangsih, S., Nurhisan, L., Zaini, M., Oktavianti, S., Pratiwi, S., Pradesa, MG, Anthony, G., Sari, D. Wi. R., Purnama, RC, Puspitasari, WRM, Rajagukguk, MJ, Van Diepen, M., & Rotmans, J. (2025). Prevalence, incidence and risk factors of chronic kidney disease in people with diabetes and hypertension, and the prognosis and kidney function decline in Indonesia: A multicentre cross-sectional study in primary care centers. BMJ Open , 15 (10), e103779. https://doi.org/10.1136/bmjopen-2025-103779

Kasradze, T., Didbaridze, T., & Tchokhonelidze, I. (2025). Epidemiology of Vascular Access-Associated Infections in Hemodialysis: A Single-Center Retrospective Study in Tbilisi, Georgia (January 2022–January 2025). Cureus . https://doi.org/10.7759/cureus.94959

Kotwal, S., Cass, A., Coggan, S., Gray, N.A., Jan, S., McDonald, S., Polkinghorne, K.R., Rogers, K., Talaulikar, G., Di Tanna, G.L., & Gallagher, M. (2022). Multifaceted intervention to reduce hemodialysis catheter related bloodstream infections: REDUCCTION stepped wedge, cluster randomized trial. BMJ (Clinical Research Ed.) , 377 , e069634. https://doi.org/10.1136/bmj-2021-069634

Lok, CE, Huber, TS, Lee, T., Shenoy, S., Yevzlin, AS, Abreo, K., Allon, M., Astor, BC, Glickman, MH, Graham, J., Moist, LM, Rajan, DK, Roberts, C., Vachharajani, TJ, & Valentini, RP (2020). KDOQI Clinical Practice Guideline For Vascular Access: 2019 Update. AJKD , 75 (4), S1–S164.

Miao, P., Tan, Z., Yao, C., Cai, Z., Feng, Y., & Yu, Z. (2025). Mortality outcomes associated with vascular access types in hemodialysis for ESRD: A systematic review and meta-analysis. BMC Nephrology , 27 (1), 67. https://doi.org/10.1186/s12882-025-04686-z

Miller, L.M., Clark, E., Dipchand, C., Hiremath, S., Kappel, J., Kiaii, M., Lok, C., Luscombe, R., Moist, L., Oliver, M., MacRae, J., & on behalf of the Canadian Society of Nephrology Vascular Access Work Group. (2016). Hemodialysis Tunneled Catheter-Related Infections. Canadian Journal of Kidney Health and Disease , 3 , 2054358116669129. https://doi.org/10.1177/2054358116669129

O'Grady, N.P., Alexander, M., Burns, L.A., Dellinger, E.P., Garland, J., Heard, S.O., Lipsett, P.A., Masur, H., Mermel, L.A., Pearson, M.L., Raad, II, Randolph, A., Rupp, M.E., & Saint, S. (2024, April 12). Background Information: Terminology and Estimates of Risk . CDC.

Righetti, M., Palmieri, N., Bracchi, O., Prencipe, M., Bruschetta, E., Colombo, F., Brenna, I., Stefani, F., Amar, K., Scalia, A., & Conte, F. (2016). Tegaderm TM CHG dressing significantly improves catheter-related infection rate in hemodialysis patients. The Journal of Vascular Access , 17 (5), 417–422. https://doi.org/10.5301/jva.5000596

Roderman, N., Moore, K., Wilcox, S., Jellerson, J., & Bridges, Z. (2024). Central Line-Associated Bloodstream Infection Reduction in Hemodialysis Patients Across 9 Hospitals and 3 States. HCA Healthcare Journal of Medicine , 5 (5). https://doi.org/10.36518/2689-0216.1910

Roşu, C.D., Bolintineanu, S.L., Căpăstraru, B.F., Iacob, R., Stoicescu, E.R., & Petrea, C.E. (2025). Risk Factor Analysis in Vascular Access Complications for Hemodialysis Patients. Diagnostics , 15 (1), 88. https://doi.org/10.3390/diagnostics15010088

Shiri, H., Nassary, Z., Behbahani, M., Torghi, M.T., & Sedghifard, Z. (2015). Comparing the effects of chlorhexidine and povidone-iodine on bacterial colonization and local infection at Shaldon catheter insertion site among patients receiving hemodialysis. Iran J Crit C Are Nurs. , 8 (1), 21–26.

Xu, H., Zhu, M., Xu, S., & Bian, L. (2024). Improving central venous catheter care with chlorhexidine gluconate dressings: Evidence from a systematic review and Meta-analysis. Journal of Health, Population and Nutrition , 43 (1), 177. https://doi.org/10.1186/s41043-024-00672-7

Zimbudzi, E. (2012). Suitability of chlorhexidine impregnated dressings on dialysis catheters in an acute dialysis setting: Lessons from our experience. International Journal of Infection Control , 8 (3). https://doi.org/10.3396/ijic.v8i3.030.12

Zrimšek, M., & Gubenšek, J. (2026). Comparable rates of catheter-related bloodstream infections between non-tunneled and tunneled hemodialysis catheters: A retrospective single-center study. Clinical Kidney Journal , 19 (1), sfaf392. https://doi.org/10.1093/ckj/sfaf392

Downloads

Published

2026-05-04

How to Cite

Hariyanti, S., Yulia, Y., & Kurnia, D. A. (2026). Effectiveness of Various Chlorhexidine-Based Insertion Site Protocols in Preventing CRBSI among Hemodialysis Patients: A Systematic Review and Synthesis Without Meta-analysis (SWiM). Indonesian Journal of Global Health Research, 8(4), 63–80. https://doi.org/10.37287/ijghr.v8i4.2012

Similar Articles

<< < 19 20 21 22 23 24 25 26 27 28 > >> 

You may also start an advanced similarity search for this article.